Artiva biotherapeutics inc ARTV.US 總覽分析

ARTV 投資分析

ARTV 近期報酬表現

與 ARTV 同產業的標的表現

• IKNA Ikena oncology inc

  價值 3 分趨勢 3 分波段 3 分籌碼 2 分股利 1 分

  查看更多
• ARQT Arcutis biotherapeutics inc
• LENZ Lenz therapeutics inc
• CRL Charles river laboratories international inc
• IRON Disc medicine inc
• OCX Oncocyte corp
• ERAS Erasca inc
• BCAX Bicara therapeutics inc
• APGE Apogee therapeutics inc
• MIST Milestone pharmaceuticals inc

ARTV 公司資訊

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. Its product candidates are derived from donor cells (allogeneic) rather than a patient's own cells (autologous) and are pre-manufactured, stored frozen and ready to ship to a patient's treatment location. Its lead product candidate, AlloNK, is being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs) in patients with autoimmune diseases and cancers, such as systemic lupus erythematosus (SLE), lupus nephritis (LN), RA, PV, the ANCA-associated vasculitis subtypes GPA/MPA, and B-NHL. AlloNK is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted mAbs in an ongoing Phase I/Ib trial in SLE with or without LN and a basket investigator-initiated trial (IIT) in multiple autoimmune indications.